logo

For the Inventor, By the Inventor

Los Angeles, CA, United States of America

Response Genetics, Inc.

Calculating rank
USPTO Granted Patents = 16

% Expired Patents = 37.5


Forward Citations = 140

Loading Chart...
Loading Chart...

3 inventors (with patents filed for the assignee):

goldMedal Kathleen D Danenberg (14 out of 26 patents)

silverMedal Glenda G Anderson (1 out of 4 patents)

bronzeMedal Craig Stephens (1 out of 1 patent)


16 patents:

1. 8977506 - Systems and methods for detecting biological features (2015-03-10),
2. 8728763 - Methods, primers, probes and kits useful for the detection of BRAF mutations (2014-05-20),
3. 8586311 - Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression (2013-11-19),
4. 8026062 - Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors (2011-09-27),
5. 7732144 - [object Object] (2010-06-08),
6. 7560543 - [object Object] (2009-07-14),
7. 7138507 - Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expression (2006-11-21),
8. 7132238 - Method of determining a chemotherapeutic regimen based on ERCC1 expression (2006-11-07),
9. 7049059 - Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression (2006-05-23),
10. 6956111 - Method of determining dihydropyrimidine dehydrogenase gene expression (2005-10-18),
11. 6905821 - Method of determining Dihydropyrimidine dehydrogenase gene expression (2005-06-14),
12. 6686155 - Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression (2004-02-03),
13. 6602670 - Method of determining a chemotherapeutic regimen based on ERCC1 expression (2003-08-05),
14. 6582919 - Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates (2003-06-24),
15. 6573052 - Method of determining a chemotherapeutic regimen based on ERCCI expression (2003-06-03),
Company Overview
Response Genetics, Inc. is a biotechnology company based in Los Angeles, California, specializing in molecular diagnostics for cancer. The organization focuses on developing innovative tests that help guide treatment decisions for patients with various types of cancer. By leveraging advanced genomic technologies, Response Genetics aims to provide insights into tumor biology, enabling personalized medicine approaches. Their research efforts contribute to the evolving landscape of cancer treatment, emphasizing the importance of tailored therapies in improving patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

16 Patents

#129 in Los Angeles, CA

#4,792 in California

#19,966 in US

#37,952 in the World

Los Angeles, CA (US)
Los Angeles, CA, United States of America

Response Genetics, Inc.

Forward Citations = 140

3 inventors:

goldMedal Kathleen D Danenberg (14 out of 26 patents)

silverMedal Glenda G Anderson (1 out of 4 patents)

bronzeMedal Craig Stephens (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Response Genetics, Inc.. Retrieved from https://idiyas.com/company/response-genetics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…